BBNX - Beta Bionics, Inc. Common Stock
Beta Bionics, Inc. Common Stock Logo

BBNX - Beta Bionics, Inc. Common Stock

https://www.betabionics.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company is headquartered in Irvine, California.

52W High
$24.50
52W Low
$8.89
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
N/A
Valuation
As of 2023-12-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
16.81
P/S (TTM) (<3 favorable)
17.82
P/B (<3 favorable)
N/A
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
6.74%
Institutions (25–75% balanced)
55.22%
Shares Outstanding
43,334,300
Float
41,336,500
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2023-12-31 (Overview)
Revenue (TTM)
53,034,000
Gross Profit (TTM)
29,261,000
EPS (TTM)
-1.30
Profit Margin (>10% good)
-1.05%
Operating Margin (TTM) (higher better)
-0.66%
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
4.40
Momentum
Bearish momentum
Value
3.0450
Previous
2.7888
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025